Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BDCA1+ cDC2s, BDCA2+ pDCs and BDCA3+ cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients.
Sosa Cuevas E, Ouaguia L, Mouret S, Charles J, De Fraipont F, Manches O, Valladeau-Guilemond J, Bendriss-Vermare N, Chaperot L, Aspord C. Sosa Cuevas E, et al. Among authors: manches o. Clin Transl Immunology. 2020 Nov 24;9(11):e1190. doi: 10.1002/cti2.1190. eCollection 2020. Clin Transl Immunology. 2020. PMID: 33282290 Free PMC article.
Preparation of purified lymphoma cells suitable for therapy.
Lui G, Manches O, Chaperot L, Ducrot T, Molens JP, Sotto JJ, Bensa JC, Plumas J. Lui G, et al. Among authors: manches o. Cytotherapy. 2004;6(3):235-43. doi: 10.1080/14653240410006059. Cytotherapy. 2004. PMID: 15203980
The features of circulating and tumor-infiltrating γδ T cells in melanoma patients display critical perturbations with prognostic impact on clinical outcome.
Girard P, Charles J, Cluzel C, Degeorges E, Manches O, Plumas J, De Fraipont F, Leccia MT, Mouret S, Chaperot L, Aspord C. Girard P, et al. Among authors: manches o. Oncoimmunology. 2019 Apr 17;8(8):1601483. doi: 10.1080/2162402X.2019.1601483. eCollection 2019. Oncoimmunology. 2019. PMID: 31413911 Free PMC article.
47 results